ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 824 filers reported holding ISHARES TR in Q3 2022. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,051,949 | +2.3% | 8,602 | +6.2% | 0.02% | +5.6% |
Q2 2023 | $1,028,370 | +106136.6% | 8,100 | +8.1% | 0.02% | -10.0% |
Q1 2023 | $968 | +52.2% | 7,494 | +54.6% | 0.02% | +17.6% |
Q4 2022 | $636 | -100.0% | 4,846 | -79.2% | 0.02% | -80.5% |
Q3 2022 | $2,727,000 | +292.4% | 23,315 | +294.8% | 0.09% | +295.5% |
Q2 2022 | $695,000 | -13.8% | 5,905 | -4.6% | 0.02% | -12.0% |
Q1 2022 | $806,000 | -27.2% | 6,189 | -14.7% | 0.02% | -24.2% |
Q4 2021 | $1,107,000 | +31.9% | 7,256 | +39.9% | 0.03% | +22.2% |
Q3 2021 | $839,000 | +7.0% | 5,187 | +8.3% | 0.03% | -3.6% |
Q2 2021 | $784,000 | +11.5% | 4,788 | +2.5% | 0.03% | -3.4% |
Q1 2021 | $703,000 | +8.5% | 4,670 | +9.1% | 0.03% | -6.5% |
Q4 2020 | $648,000 | -37.8% | 4,280 | -44.4% | 0.03% | -51.6% |
Q3 2020 | $1,042,000 | +36.9% | 7,697 | +38.3% | 0.06% | +16.4% |
Q2 2020 | $761,000 | +179.8% | 5,567 | +120.6% | 0.06% | +120.0% |
Q1 2020 | $272,000 | -51.0% | 2,524 | -45.2% | 0.02% | -46.8% |
Q4 2019 | $555,000 | – | 4,606 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |